ID PRPC_ABDS2 Reviewed; 379 AA. AC O34002; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1998, sequence version 1. DT 13-SEP-2023, entry version 104. DE RecName: Full=2-methylcitrate synthase {ECO:0000303|PubMed:9579066}; DE Short=2-MCS {ECO:0000303|PubMed:9579066}; DE Short=MCS {ECO:0000303|PubMed:9579066}; DE EC=2.3.3.5 {ECO:0000269|PubMed:9579066}; DE AltName: Full=Citrate synthase {ECO:0000303|PubMed:9310359}; DE EC=2.3.3.16 {ECO:0000269|PubMed:9310359, ECO:0000269|PubMed:9579066}; GN Name=gltA; Synonyms=cisY; OS Antarctic bacterium DS2-3R. OC Bacteria. OX NCBI_TaxID=56673; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-16, FUNCTION, RP CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT. RC STRAIN=DS2-3R; RX PubMed=9310359; DOI=10.1111/j.1432-1033.1997.00049.x; RA Gerike U., Danson M.J., Russell N.J., Hough D.W.; RT "Sequencing and expression of the gene encoding a cold-active citrate RT synthase from an Antarctic bacterium, strain DS2-3R."; RL Eur. J. Biochem. 248:49-57(1997). RN [2] RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, INDUCTION, AND RP SUBSTRATE SPECIFICITY. RC STRAIN=DS2-3R; RX PubMed=9579066; DOI=10.1099/00221287-144-4-929; RA Gerike U., Hough D.W., Russell N.J., Dyall-Smith M.L., Danson M.J.; RT "Citrate synthase and 2-methylcitrate synthase: structural, functional and RT evolutionary relationships."; RL Microbiology 144:929-935(1998). RN [3] RP X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 2-379 IN COMPLEX WITH COENZYME A RP AND SUBSTRATE, ACTIVE SITE, AND SUBUNIT. RC STRAIN=DS2-3R; RX PubMed=9551556; DOI=10.1016/s0969-2126(98)00037-9; RA Russell R.J., Gerike U., Danson M.J., Hough D.W., Taylor G.L.; RT "Structural adaptations of the cold-active citrate synthase from an RT Antarctic bacterium."; RL Structure 6:351-361(1998). CC -!- FUNCTION: Involved in the catabolism of short chain fatty acids (SCFA) CC via the tricarboxylic acid (TCA)(acetyl degradation route) and via the CC 2-methylcitrate cycle I (propionate degradation route). Catalyzes the CC Claisen condensation of propionyl-CoA and oxaloacetate (OAA) to yield CC 2-methylcitrate (2-MC) and CoA. Also catalyzes the condensation of CC oxaloacetate with acetyl-CoA but with a lower specificity. CC {ECO:0000269|PubMed:9310359, ECO:0000269|PubMed:9579066}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + oxaloacetate + propanoyl-CoA = (2S,3S)-2-methylcitrate + CC CoA + H(+); Xref=Rhea:RHEA:23780, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:16452, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57392, ChEBI:CHEBI:58853; EC=2.3.3.5; CC Evidence={ECO:0000269|PubMed:9579066}; CC -!- CATALYTIC ACTIVITY: CC Reaction=acetyl-CoA + H2O + oxaloacetate = citrate + CoA + H(+); CC Xref=Rhea:RHEA:16845, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16452, ChEBI:CHEBI:16947, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:57288; EC=2.3.3.16; Evidence={ECO:0000269|PubMed:9310359, CC ECO:0000269|PubMed:9579066}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=3 uM for oxaloacetate (with propionyl-CoA at pH 8 and 23 degrees CC Celsius) {ECO:0000269|PubMed:9579066}; CC KM=6.9 uM for oxaloacetate (with acetyl-CoA at pH 8 and 23 degrees CC Celsius) {ECO:0000269|PubMed:9310359}; CC KM=7 uM for oxaloacetate (with acetyl-CoA at pH 8 and 23 degrees CC Celsius) {ECO:0000269|PubMed:9579066}; CC KM=16 uM for propionyl-CoA (at pH 8 and 23 degrees Celsius) CC {ECO:0000269|PubMed:9579066}; CC KM=229 uM for acetyl-CoA (at pH 8 and 23 degrees Celsius) CC {ECO:0000269|PubMed:9579066}; CC KM=230 uM for acetyl-CoA (at pH 8 and 23 degrees Celsius) CC {ECO:0000269|PubMed:9310359}; CC Vmax=12 umol/min/mg enzyme with propionyl-CoA as substrate (at pH 8 CC and 23 degrees Celsius) {ECO:0000269|PubMed:9579066}; CC Vmax=30 umol/min/mg enzyme with acetyl-CoA as substrate (at pH 8 and CC 23 degrees Celsius) {ECO:0000269|PubMed:9310359, CC ECO:0000269|PubMed:9579066}; CC Note=kcat is 8 sec(-1) for 2-methylcitrate synthase activity with CC propionyl-CoA as substrate (at pH 8 and 23 degrees Celsius). kcat is CC 21 sec(-1) for citrate synthase activity with acetyl-CoA as substrate CC (at pH 8 and 23 degrees Celsius). {ECO:0000269|PubMed:9310359, CC ECO:0000269|PubMed:9579066}; CC Temperature dependence: CC Optimum temperature is 31 degrees Celsius. Cold-active. Is rapidly CC inactivated at 45 degrees Celsius, and shows significant activity at CC 10 degrees Celsius and below. {ECO:0000269|PubMed:9310359}; CC -!- PATHWAY: Organic acid metabolism; propanoate degradation. CC {ECO:0000305|PubMed:9579066}. CC -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; isocitrate CC from oxaloacetate: step 1/2. {ECO:0000305|PubMed:9579066}. CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:9310359, CC ECO:0000269|PubMed:9551556}. CC -!- INDUCTION: By growth on propionate, but not acetate or glucose. CC {ECO:0000269|PubMed:9579066}. CC -!- SIMILARITY: Belongs to the citrate synthase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U85944; AAC45662.1; -; Genomic_DNA. DR PDB; 1A59; X-ray; 2.09 A; A=2-379. DR PDBsum; 1A59; -. DR AlphaFoldDB; O34002; -. DR SMR; O34002; -. DR DrugBank; DB04272; Citric acid. DR DrugBank; DB01992; Coenzyme A. DR BRENDA; 2.3.3.1; 15675. DR SABIO-RK; O34002; -. DR UniPathway; UPA00223; UER00717. DR UniPathway; UPA00946; -. DR EvolutionaryTrace; O34002; -. DR GO; GO:0005737; C:cytoplasm; IEA:InterPro. DR GO; GO:0050440; F:2-methylcitrate synthase activity; IDA:UniProtKB. DR GO; GO:0036440; F:citrate synthase activity; IDA:UniProtKB. DR GO; GO:0019679; P:propionate metabolic process, methylcitrate cycle; IDA:UniProtKB. DR GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-UniPathway. DR CDD; cd06111; DsCS_like; 1. DR Gene3D; 1.10.580.10; Citrate Synthase, domain 1; 1. DR Gene3D; 1.10.230.10; Cytochrome P450-Terp, domain 2; 1. DR InterPro; IPR011278; 2-MeCitrate/Citrate_synth_II. DR InterPro; IPR016142; Citrate_synth-like_lrg_a-sub. DR InterPro; IPR016143; Citrate_synth-like_sm_a-sub. DR InterPro; IPR002020; Citrate_synthase. DR InterPro; IPR019810; Citrate_synthase_AS. DR InterPro; IPR024176; Citrate_synthase_bac-typ. DR InterPro; IPR036969; Citrate_synthase_sf. DR NCBIfam; TIGR01800; cit_synth_II; 1. DR PANTHER; PTHR11739; CITRATE SYNTHASE; 1. DR PANTHER; PTHR11739:SF4; CITRATE SYNTHASE, PEROXISOMAL; 1. DR Pfam; PF00285; Citrate_synt; 1. DR PIRSF; PIRSF001369; Citrate_synth; 1. DR PRINTS; PR00143; CITRTSNTHASE. DR SUPFAM; SSF48256; Citrate synthase; 1. DR PROSITE; PS00480; CITRATE_SYNTHASE; 1. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Transferase; KW Tricarboxylic acid cycle. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:9310359" FT CHAIN 2..379 FT /note="2-methylcitrate synthase" FT /id="PRO_0000169925" FT ACT_SITE 222 FT /evidence="ECO:0000269|PubMed:9551556" FT ACT_SITE 270 FT /evidence="ECO:0000269|PubMed:9551556" FT ACT_SITE 321 FT /evidence="ECO:0000269|PubMed:9551556" FT BINDING 187 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:I6Y9Q3" FT BINDING 264..268 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000269|PubMed:9551556" FT BINDING 279 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:9551556" FT BINDING 346 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:9551556" FT BINDING 365 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:I6Y9Q3" FT HELIX 8..10 FT /evidence="ECO:0007829|PDB:1A59" FT STRAND 19..24 FT /evidence="ECO:0007829|PDB:1A59" FT TURN 25..28 FT /evidence="ECO:0007829|PDB:1A59" FT STRAND 29..32 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 37..43 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 46..55 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 61..72 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 79..85 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 94..107 FT /evidence="ECO:0007829|PDB:1A59" FT TURN 110..113 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 117..142 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 156..165 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 171..184 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 191..200 FT /evidence="ECO:0007829|PDB:1A59" FT TURN 201..203 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 206..218 FT /evidence="ECO:0007829|PDB:1A59" FT TURN 220..224 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 225..235 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 244..260 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 280..293 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 298..314 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 321..330 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 335..337 FT /evidence="ECO:0007829|PDB:1A59" FT HELIX 338..359 FT /evidence="ECO:0007829|PDB:1A59" SQ SEQUENCE 379 AA; 41832 MW; 7D8F4614E3D1CC9F CRC64; MTEPTIHKGL AGVTADVTAI SKVNSDTNSL LYRGYPVQEL AAKCSFEQVA YLLWNSELPN DSELKAFVNF ERSHRKLDEN VKGAIDLLST ACHPMDVART AVSVLGANHA RAQDSSPEAN LEKAMSLLAT FPSVVAYDQR RRRGEELIEP REDLDYSANF LWMTFGEEAA PEVVEAFNVS MILYAEHSFN ASTFTARVIT STLADLHSAV TGAIGALKGP LHGGANEAVM HTFEEIGIRK DESLDEAATR SKAWMVDALA QKKKVMGFGH RVYKNGDSRV PTMKSALDAM IKHYDRPEML GLYNGLEAAM EEAKQIKPNL DYPAGPTYNL MGFDTEMFTP LFIAARITGW TAHIMEQVAD NALIRPLSEY NGPEQRQVP //